Recursion Pharmaceuticals, Inc. RXRX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s change in AP?
- Recursion Pharmaceuticals, Inc. (RXRX) reported change in AP of $2.07M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s change in AP decreased by 43.9% year-over-year, from $3.69M to $2.07M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.